| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President And CEO
1 company
McCarthy Sean A. is a CEO at CytomX Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 300 | $15.00 | $4,500.00 | -6.6% | |
| May 1, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 4,781 | $15.70 | $75,061.70 | -70.7% | |
| Apr 4, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 9,562 | $17.22 | $164,657.64 | -70.7% | |
| Mar 20, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 14,343 | $19.60 | $281,122.80 | -87.9% | |
| Mar 3, 2017 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sale+OE | 14,343 | $15.00 | $215,145.00 | -87.9% |